Experimental tuberculosis in the wistar rat: A model for protective immunity and control of infection

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Singhal, Amit ^a,g   Aliouat, El Moukhtar ^b   Hervé, Maxime ^a   Mathys, Vanessa ^c   Kiass, Mehdi ^c   Creusy, Colette ^d   Delaire, Baptiste ^d   Tsenova, Liana ^e   Fleurisse, Laurence ^d   Bertout, Julie ^f   Camacho, Luis ^a   Foo, Damian ^a   Tay, Hui Chien ^a   Siew, Jie Yee ^a   Boukhouchi, Warda ^c   Romano, Marta ^c   Mathema, Barun ^e   Dartois, Véronique ^a   Kaplan, Gilla ^e   Bifani, Pablo ^a  

^a NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^b UNIV LILLE   (France)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^e PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^f INSTITUT PASTEUR DE LILLE   (France)

^g AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GROWTH REGULATION; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; INFECTION RESISTANCE; LYMPHOCYTE ACTIVATION; NONHUMAN; POSTPRIMARY TUBERCULOSIS; RAT; TH1 CELL; TUBERCULOSIS; TUBERCULOSIS CONTROL; WISTAR RAT; ANIMAL; DISEASE MODEL; IMMUNOLOGY;

ANIMALIA; MYCOBACTERIUM TUBERCULOSIS; RATTUS; RATTUS NORVEGICUS;

ANIMALS; DISEASE MODELS, ANIMAL; RATS; RATS, WISTAR; TUBERCULOSIS;

EID: 79954611256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018632     Document Type: Article

References (37)

1. Migliori GB, Matteelli A, Cirillo D, Pai M, (2008) Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges. Can J Infect Dis Med Microbiol 19: 169-172.
2. Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, et al. (2007) Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 13: 380-387.
3. Migliori GB, Loddenkemper R, Blasi F, Raviglione MC, (2007) 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J 29: 423-427.
4. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, et al. (2006) Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194: 479-485.
5. Flynn JL, Chan J, (2003) Animal models of tuberculosis. In: Rom SMG, editors. Tuberculosis. 2nd edn Philadelphia Lippincott, Williams & Wilkins pp. 237-250.
6. McMurray DN, (1994) Guinea pig model of tuberculosis. In: Bloom BR, editors. Tuberculosis: pathogenesis, protection and control Washington, SC ASM Press pp. 135-147.
7. Dannenberg AM, (1994) Rabbit model of tuberculosis. In: Bloom BR, editors. Tuberculosis: pathogenosis, protection and control Washington, SC ASM Press pp. 135-147.
8. Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, et al. (2005) Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 192: 98-106.
9. Flynn JL, Tsenova L, Izzo A, Kaplan G, (2008) Experimental Animal Models of Tuberculosis. In: Kaufmann SH, Britton WJ, editors. Handbook of Tuberculosis: Immunology and Cell Biology Weinheim WILEY-VCH Verlag GmbH & Co. KGaA.
10. Capuano SV 3rd, Croix DA, Pawar S, Zinovik A, Myers A, et al. (2003) Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 71: 5831-5844.
11. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, et al. (2009) Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun.
12. Glyone SR, Page DS, (1923) The reaction to B. tuberculosis in the albino rat. J Pathol Bacteriol 26: 224-233.
13. Ornstein GB, Steinbach MM, (1925) The resistance of the albino rat to infection with tubercle bacilli. Am Rev Tuberc 12: 77-86.
14. Wessels CC, (1941) Tuberculosis in the rat. II. The fate of tubercle bacilli in the various organs of the rat. Am Rev Tuberc 43: 459-474.
15. Flax MH, Waksman BH, (1962) Delayed cutaneous reactions in the rat. J Immunol 89: 496-504.
16. Gray DF, (1961) The relative natural resistance of rats and mice to experimental pulmonary tuberculosis. J Hyg (Lond) 59: 471-477.
17. Lefford MJ, McGregor DD, Mackaness GB, (1973) Immune response to Mycobacterium tuberculosis in rats. Infect Immun 8: 182-189.
18. Sugawara I, Yamada H, Mizuno S, (2004) Pathological and immunological profiles of rat tuberculosis. Int J Exp Pathol 85: 125-134.
19. Sugawara I, Yamada H, Mizuno S, (2004) Pulmonary tuberculosis in spontaneously diabetic goto kakizaki rats. Tohoku J Exp Med 204: 135-145.
20. Sugawara I, Yamada H, Mizuno S, (2006) Nude rat (F344/N-rnu) tuberculosis. Cell Microbiol 8: 661-667.
21. Young D, (2009) Animal models of tuberculosis. Eur J Immunol 39: 2011-2014.
22. Lin PL, Flynn JL, (2010) Understanding latent tuberculosis: A moving target. J Immunol 185: 15-22.
23. Basaraba RJ, (2008) Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb) 88 (Suppl 1): S35-47.
24. Dvorak AM, Dvorak HF, Peters SP, Shulman ES, MacGlashan DW Jr, et al. (1983) Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J Immunol 131: 2965-2976.
25. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, et al. (2008) Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4: e1000204.
26. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, et al. (2001) Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci U S A 98: 5752-5757.
27. Reed MB, Domenech P, Manca C, Su H, Barczak AK, et al. (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431: 84-87.
28. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, et al. (2007) The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J Immunol 179: 522-531.
29. Davis JM, Ramakrishnan L, (2009) The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136: 37-49.
30. Orme M, (2001) The latent tuberculosis bacillus (I'll let you know if I ever meet one). Int J Tuberc Lung Dis 5: 589-593.
31. Rothel JS, Andersen P, (2005) Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 3: 981-993.
32. McCune RM, Tompsett R Jr, (1956) Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med 104: 737-762.
33. Elwood RL, Rajnik M, Wilson S, Yim K, Blanco JC, et al. (2009) Characterization of late tuberculosis infection in Sigmodon hispidus. Tuberculosis (Edinb) 89: 183-188.
34. Bifani PJ, Mathema B, Liu Z, Moghazeh SL, Shopsin B, et al. (1999) Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 282: 2321-2327.
35. Jimenez E, Martínez A, Aliouat el M, Caballero J, Dei-Cas E, Gargallo-Viola D, (2002) Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models. Antimicrob Agents Chemother 46: 2648-2650.
36. Singhal A, Aliouat EM, Creusy C, Kaplan G, Bifani PJ, (2010) Pulmonary tuberculosis in rats. In: Leong JF, Dartois V, Dick T, editors. A color atlas of comparative pathology of pulmonary tuberculosis Routledge, Taylor and Francis Inc pp. 157-173.
37. Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J, (1988) Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol 27: 187-194.